Pankaj Kumar

6PUBLICATIONS
48CO-AUTHORS
Haematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 16, 2025
Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826.

Sarah C Rutherford, Hongli Li, Alex F Herrera

|Jun 18, 2024
Improved Survival With Adjuvant Cyclooxygenase 2 Inhibition in PIK3CA-Activated Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance).

Jonathan A Nowak, Tyler Twombly, Chao Ma

|Jun 08, 2023
Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance).

Qiao-Li Wang, Chao Ma, Chen Yuan

|Nov 11, 2022
Potential Mediators of Oxaliplatin-Induced Peripheral Neuropathy From Adjuvant Therapy in Stage III Colon Cancer: Findings From CALGB (Alliance)/SWOG 80702.

Seohyuk Lee, Chao Ma, Qian Shi

|Aug 09, 2022
Physical Activity in Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance).

Justin C Brown, Chao Ma, Qian Shi

Pageof 1